PATIENTS TAKING VIMOVO TM SHOWED DECREASE IN INCIDENCE OF NSAID ASSOCIATED ULCERS
AstraZeneca and POZEN Inc. today announced pivotal data from two POZEN clinical trials that were presented at the American College of Rheumatology (ACR) 2009 Annual Scientific Meeting in Philadelphia, PA.